Catalent Pharma Solutions operates a leading pharmaceutical facility located at 2725 Scherer Dr, St. Petersburg, Florida. This company specializes in softgel development and manufacturing, focusing on enhancing the bioavailability of poorly soluble prescription and over-the-counter drug candidates. The facility utilizes the advanced RP Scherer softgel technology, recognized for its effectiveness in oral drug delivery.
St. Petersburg serves as the primary hub for Catalent's softgel solutions in North America. The company provides innovative non-gelatin based OptiShell® and Vegicaps® capsules, which cater to a wide range of molecules, making them ideal for challenging fill formulations. Catalent's expertise in this area addresses the complex needs of pharmaceutical development, ensuring that clients receive tailored solutions for their specific requirements.
Within the Catalent network, a comprehensive array of integrated formulation and analytical services is available. This approach allows for the resolution of intricate development and manufacturing challenges faced by clients in the pharmaceutical industry. With a commitment to quality and innovation, Catalent Pharma Solutions enhances the overall efficiency and effectiveness of drug delivery systems.
Catalent Pharma Solutions excels in providing advanced softgel technology and a broad range of services in St. Petersburg, Florida. The company’s focus on quality and innovation positions it as a valuable partner in the pharmaceutical sector. Reach out to Catalent Pharma Solutions for expert assistance with pharmaceutical development and manufacturing needs in St. Petersburg.
